Is OSE Immunotherapeutics SA halal to invest in?

According to Musaffa's Shariah screening methodology, OSE Immunotherapeutics SA (OSE.PA) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is OSE Immunotherapeutics SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes OSE Immunotherapeutics SA using these criteria to determine its compliance status.

Can Muslims buy shares of OSE Immunotherapeutics SA?

Muslim investors may consider investing in OSE Immunotherapeutics SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is OSE Immunotherapeutics SA classified as NOT HALAL?

Musaffa determines the Shariah status of OSE Immunotherapeutics SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for OSE Immunotherapeutics SA updated?

The Shariah compliance status of OSE Immunotherapeutics SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like OSE Immunotherapeutics SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of OSE Immunotherapeutics SA?

You can check the latest Shariah compliance status of OSE Immunotherapeutics SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

OSE Immunotherapeutics SA OSE.PA

€5.60 €0.61 (12.22%) 1D

Last Updated: May 15, 12:00 AM·XPAR

OSE.PA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: February 12, 2026

Report Source: 2025 2nd Quarter Report

Analyst's Ratings for OSE Immunotherapeutics SA (OSE.PA)

Based on 7 analysts giving stock ratings to OSE Immunotherapeutics SA in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

OSE Immunotherapeutics SA. Stock Analysis OSE.PA

France Health Care Micro Cap Report: Q2, 2025

OSE Immunotherapeutics SA s is a biotechnology company, which engages in the research and development of pharmaceutical products. The company develops immunotherapies, directly or through partnerships, for the activation and regulation of the immune system in immuno-oncology and in autoimmune diseases. The firm's research and development in immunology is based on 3 platforms, such as T cell-based vaccines, Immuno-Oncology (myeloid targets) and Auto-Immunity & Inflammation. The company provides technological and scientific platforms: neoepitopes, agonist or antagonist monoclonal antibodies, ideally positioned to fight cancer and autoimmune diseases.

Key Statistics of OSE Immunotherapeutics SA (OSE.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€4.99€5.82

Today's Open

€4.99

Volume

76.57K

P/E Ratio (TTM)

52 Week Range

€2.87€7.70

Market Cap

81.69M

Avg. Volume

43.02K

Dividend Yield

Financial Metrics & Statements of OSE Immunotherapeutics SA (OSE.PA)

FAQ's for OSE Immunotherapeutics SA (OSE.PA)

According to Musaffa’s Shariah screening methodology, OSE Immunotherapeutics SA (OSE.PA) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.